Advertisement
Screener

Myovant Sciences Ltd. Deferred Tax Assets, Net of Valuation Allowance

Myovant Sciences Ltd. Deferred Tax Assets, Net of Valuation Allowance

Myovant Sciences Ltd. had Deferred Tax Assets, Net of Valuation Allowance of $2.27 million as of 2022-03-31, per its 10-K filed 2022-05-11.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance

us-gaap:DeferredTaxAssetsNet · last filed 2022-05-11

  • 2022-03-31: Deferred Tax Assets, Net of Valuation Allowance $2.27M.
  • 2021-03-31: Deferred Tax Assets, Net of Valuation Allowance $2.69M.
  • 2017-03-31: Deferred Tax Assets, Net of Valuation Allowance $208.00K.
  • 2016-03-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
Period endDeferred Tax Assets, Net of Valuation Allowance
2022-03-31$2.27M
10-K · filed 2022-05-11
2021-03-31$2.69M
10-K · filed 2022-05-11
2017-03-31$208.00K
10-K · filed 2017-06-14
2016-03-31$0.00
10-K · filed 2017-06-14